{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:25:42Z","timestamp":1793607942613,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["LRP 1 L30 CA231572-01"],"award-info":[{"award-number":["LRP 1 L30 CA231572-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2018-2022"],"award-info":[{"award-number":["2018-2022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CSDG-20-013-01-CCE"],"award-info":[{"award-number":["CSDG-20-013-01-CCE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:28:48Z","timestamp":1746710928000},"page":"654-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The epidemiology of Merkel cell carcinoma in the United States"],"prefix":"10.1016","volume":"93","author":[{"given":"Nathan J.","family":"Fakult","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie R.","family":"Deighen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Cullison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.","family":"Rothermel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","article-title":"Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study","volume":"37","author":"Albores-Saavedra","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.jaad.2025.05.001_bib2","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2025.05.001_bib3","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ejca.2013.02.029","article-title":"Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project","volume":"49","author":"van der Zwan","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2025.05.001_bib4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/000313481508100819","article-title":"Dramatic increase in the incidence and mortality from merkel cell carcinoma in the United States","volume":"81","author":"Fitzgerald","year":"2015","journal-title":"Am Surg"},{"issue":"8","key":"10.1016\/j.jaad.2025.05.001_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.05.001_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: current US incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.001_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/bjd\/ljad404","article-title":"Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies","volume":"190","author":"Mohsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.05.001_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2021.07.020","article-title":"Incidence and risk factors for early mortality in adults with skin Merkel cell carcinoma: a SEER-based study","volume":"86","author":"Wang","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.001_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaad.2019.01.042","article-title":"Treatment and survival of Merkel cell carcinoma since 1993: a population-based cohort study in The Netherlands","volume":"81","author":"Uitentuis","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.001_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaad.2018.10.045","article-title":"Merkel cell carcinoma incidence, trends, and survival rates among adults aged >50 years from United States cancer statistics","volume":"80","author":"Freeman","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.05.001_bib11","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/jdv.13698","article-title":"Merkel cell carcinoma incidence is increasing in Sweden","volume":"30","author":"Zaar","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.001_bib12","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1111\/ajd.13023","article-title":"Epidemiology and survival of Merkel cell carcinoma in New Zealand: a population-based study between 2000 and 2015 with international comparison","volume":"60","author":"Lee","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.05.001_bib13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0190-9622(03)02108-X","article-title":"Epidemiology of primary Merkel cell carcinoma in the United States","volume":"49","author":"Agelli","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.05.001_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jnci\/djq120","article-title":"Merkel cell carcinoma: incidence, mortality, and risk of other cancers","volume":"102","author":"Kaae","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.jaad.2025.05.001_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejca.2011.06.001","article-title":"Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases","volume":"48","author":"Kukko","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2025.05.001_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canep.2016.09.001","article-title":"Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: a population-based study","volume":"45","author":"Rubi\u00f3-Casadevall","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamadermatol.2020.4102","article-title":"Assessment of age, period, and birth cohort effects and trends in merkel cell carcinoma incidence in the United States","volume":"157","author":"Jacobs","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.001_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.31860","article-title":"Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France","volume":"144","author":"Kieny","year":"2019","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.jaad.2025.05.001_bib19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/sim.7215","article-title":"Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.jaad.2025.05.001_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"Tiwari","year":"2006","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.05.001_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib24","first-page":"77","article-title":"Fitting segmented regression models by grid search","volume":"29","author":"Lerman","year":"1980","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"2","key":"10.1016\/j.jaad.2025.05.001_bib25","first-page":"153","article-title":"Merkel cell carcinoma and melanoma: etiological similarities and differences","volume":"8","author":"Miller","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.jaad.2025.05.001_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","article-title":"Epidemiology and survival of Merkel cell carcinoma in The Netherlands. A population-based study of 808 cases in 1993-2007","volume":"47","author":"Reichgelt","year":"2011","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archderm.1972.01620040075020","article-title":"Trabecular carcinoma of the skin","volume":"105","author":"Toker","year":"1972","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers15010103","article-title":"Merkel cell carcinoma-update on diagnosis, management and future perspectives","volume":"15","author":"Zaggana","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jaad.2025.05.001_bib29","first-page":"427","article-title":"Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies","volume":"140","author":"Moll","year":"1992","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.jaad.2025.05.001_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00000478-200009000-00004","article-title":"Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas","volume":"24","author":"Ord\u00f3\u00f1ez","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.jaad.2025.05.001_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2011.10493.x","article-title":"Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival","volume":"165","author":"Girschik","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.05.001_bib32","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/ajd.13131","article-title":"Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016","volume":"61","author":"Garbutcheon-Singh","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"7-8","key":"10.1016\/j.jaad.2025.05.001_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18632\/oncoscience.358","article-title":"Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study","volume":"4","author":"Ezaldein","year":"2017","journal-title":"Oncoscience"},{"issue":"10","key":"10.1016\/j.jaad.2025.05.001_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.6004\/jnccn.2016.0134","article-title":"Merkel cell carcinoma: a population analysis on survival","volume":"14","author":"Sridharan","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.jaad.2025.05.001_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamadermatol.2023.0061","article-title":"Differences in merkel cell carcinoma presentation and outcomes among racial and ethnic groups","volume":"159","author":"Mohsin","year":"2023","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225007042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225007042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:06:43Z","timestamp":1755648403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225007042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0190962225007042"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.001","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiology of Merkel cell carcinoma in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}